Lucid Diagnostics (LUCD) FCF Margin (2021 - 2026)
Lucid Diagnostics (LUCD) reported FCF Margin of 947.38% for Q1 2026, up 56928.0% on a YoY basis from N/an in Q1 2025, and down 12.69% quarter-over-quarter from 840.69% in Q4 2025.
Lucid Diagnostics (LUCD) FCF Margin (2021 - 2026) Analysis & Trends
Lucid Diagnostics has reported FCF Margin for 6 years, with the latest figure at 947.38% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 56928.0% year-over-year to 947.38%; the trailing twelve-month figure through Mar 2026 stood at 892.68% (up 16999.0% YoY), and the FY2025 full-year result was 992.29%, up 3017.0% from the prior year.
- FCF Margin for Q1 2026 stood at 947.38%, down from 840.69% in the prior quarter.
- The five-year high for FCF Margin was 840.69% in Q4 2025, with the low at 6382.89% in Q3 2022.
- Historically, FCF Margin has averaged 1926.44% across 5 years, with a median of 1149.84% in 2023.
- Annual changes were most pronounced in 2022 — FCF Margin slumped 527789 bps — and 2023, when it jumped 525965 bps.
- Lucid Diagnostics' FCF Margin stood at 3983.04% in 2022, then soared by 75 bps to 976.35% in 2023, then climbed by 13 bps to 846.28% in 2024, then climbed by 1 bps to 840.69% in 2025, then slipped by 13 bps to 947.38% in 2026.
- The last three FCF Margin figures came in at 947.38% (Q1 2026), 840.69% (Q4 2025), and 910.08% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.44% |
| 10 | Lucid Diagnostics | 149.20 Mn | 121.33 Mn | -325,000.00 | -947.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -947.38% |
| Dec 31, 2025 | -840.69% |
| Sep 30, 2025 | -910.08% |
| Jun 30, 2025 | -881.17% |
| Mar 31, 2025 | -1,516.67% |
| Dec 31, 2024 | -846.28% |
| Sep 30, 2024 | -868.17% |
| Jun 30, 2024 | -1,176.43% |
| Mar 31, 2024 | -1,263.64% |
| Dec 31, 2023 | -976.35% |
| Sep 30, 2023 | -1,123.24% |
| Jun 30, 2023 | -4,372.33% |
| Mar 31, 2023 | -1,600.22% |
| Dec 31, 2022 | -3,983.04% |
| Sep 30, 2022 | -6,382.89% |
| Mar 31, 2022 | -3,134.39% |
| Dec 31, 2021 | -3,567.00% |
| Sep 30, 2021 | -1,105.00% |